Overview
Align CRO is a Dallas-based contract research organization specializing in phase I-II oncology research services for emerging biotech companies. Established in 2006 as a complement to the charitable mission of Mary Crowley Cancer Research, “To bring hope to cancer patients through innovative clinical trials while advancing treatment for patients in the future”; the CRO has proven to be an instrumental partner in shepherding emerging cancer technologies from bench to bedside. Align CRO serves the ultimate goal of expediting clinical research and driving promising investigational agents toward FDA approval.
STUDY Start-up
Study start-up is a crucial point and at Align we understand its importance for a successful trial.
Project Management
The Project Manager maintains open communication to ensure project success.
Clinical Data Management (CDM)
High quality, reliable and statistically sound data are Aligns top priority.
